-
Tempus AI Strikes $200M Deal With AstraZeneca, Pathos To Build World's Largest Oncology Model
Wednesday, May 7, 2025 - 5:03am | 677Tempus AI Inc. (NASDAQ:TEM) during the first quarter secured a multi-million dollar deal to build “the world’s largest foundation model for oncology.” What Happened: During its first-quarter earnings call on Tuesday, Tempus shed light on its new $200 million, three-year data and...
-
Tempest Weighs M&A, Analyst Sees A "Broken Story" Despite Phase 2 Liver Cancer Study Success
Thursday, April 10, 2025 - 12:00pm | 536Tempest Therapeutics, Inc. (NASDAQ:TPST) said on Thursday it had retained MTS Health Partners as a financial advisor. The company plans to explore strategic alternatives to advance its clinical-stage programs and maximize stockholder value. Strategic alternatives may include M&A, partnerships,...
-
EXCLUSIVE: 2024 Witnesses Increase In Biotech Initial Public Offerings
Thursday, March 21, 2024 - 3:04pm | 683At the recent Benzinga Virtual Healthcare Summit, Laura Chico, Ph.D., senior vice president of equity research at Wedbush Equity Research, shared her optimistic views on the 2024 biotech IPO market and the current M&A trends in the industry. Chico’s discussion happened against the...
-
The Latest Barron's Picks And Pans: Meme Stocks, AstraZeneca, Citigroup And More
Sunday, July 11, 2021 - 9:43am | 1059The cover story in this weekend's Barron's reveals what investors should know now about the so-called meme stocks. Other featured articles discuss how to find bargains in Chinese stocks, the increasing likelihood of big tech regulation and how travel and leisure stocks have fared lately....
-
Barron's Latest Picks And Pans: DuPont, Stanley Black & Decker, Whirlpool And More
Sunday, May 16, 2021 - 11:31am | 1195This weekend's Barron's helps investors identify stay-at-home stocks that still have room to run. Other featured articles discuss ways investors can hedge against inflation and an investing strategy that brings growth and reasonable yield. Also, see the prospects for a home appliance maker...
-
FDA, CDC Officials Discuss Johnson & Johnson Vaccine: A 'Pause Recommendation', Resolution Timeline And Advisory
Tuesday, April 13, 2021 - 3:08pm | 856The Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) handed down a recommendation to pause the use of Johnson & Johnson's (NYSE: JNJ) COVID-19 vaccine. In a joint audio press conference hosted by Acting FDA Commissioner Janet Woodcock,...
-
Benzinga's Bulls And Bears Of The Week: Apple, Chevron, GM, GE, Peloton And More
Saturday, April 10, 2021 - 12:05pm | 1320Benzinga has examined the prospects for many investor favorite stocks over the past week. The past week's bullish calls included the iPhone maker, Google's parent and an automotive leader. Financial and energy giants and COVID-19 vaccine makers were among the bearish calls seen during the...
-
Fed Minutes Later Today Loom Large As Investors Seek Insight Into FOMC's Next Steps
Wednesday, April 7, 2021 - 10:49am | 2381It’s been a dull week so far, but things pick up starting today in case you’re falling asleep. The main event comes this afternoon with minutes from the last Federal Open Market Committee (FOMC) meeting last month. The minutes are being looked at as something that could give the market...
-
Is Silicon Valley Replacing Big Pharma In Neuroscience?
Tuesday, April 6, 2021 - 8:54am | 1381The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Over the past decade, big pharma has largely stepped away from the research and development of psychiatric drugs. This came after what was...
-
Intel Helps Market Comeback As Shares Rise Following Announcement
Wednesday, March 24, 2021 - 9:58am | 1883Like spring weather, the stock market can be fickle. After yesterday’s blustery headwinds of coronavirus worry, this morning is pointing to a calmer day as stocks look to recover some ground. It seems like some end-of-quarter rebalancing activity may be behind some of the volatility, but...
-
Wednesday's Market Minute: Bulls Are Losing Their Touch
Wednesday, March 24, 2021 - 9:49am | 662The powerful rotation trade that’s been raging since September finally hit a speed bump this past week thanks to anxiety around Europe’s reliance on the AstraZeneca plc (NASDAQ: AZN) vaccine and some hiccups in the reopening here at home. Crude oil’s faceplant upon passing the $60...
-
Nasdaq Has Strong Overnight Session, Led By Tesla, As Yields Step Back
Monday, March 22, 2021 - 9:53am | 2091After a bumpy finish Friday, the road feels smoother as we start the final full week of Q1. This easy cruising might not last, however, with another appearance from Fed Chairman Jerome Powell on tap tomorrow. Some positive vaccine news and a dip in Treasury yields provided early support,...
-
Fintech Focus For March 16, 2021
Monday, March 15, 2021 - 5:56pm | 1966Quote To Start The Day: “When someone tells me something can’t be done, I think there’s always a will and a way.” Source: Randall Kaplan One Big Thing In Fintech: One driving force behind innovation is disruption. That’s according to Allison Beer, the Chief Product...
-
Barron's Latest Picks And Pans: COVID Booster Shot Plays, Defense M&As, Coty, Hologic, And More
Sunday, February 14, 2021 - 8:47am | 1123This weekend's Barron's cover story offers a look at the 100 must sustainable companies. Other featured articles discuss the changing vaccine industry, the history of electric vehicles and consolidation in the defense sector. Also, the prospects for a medical-diagnostics company, a high-...
-
'The Third Wave': Stock Market Update For The Week Ahead
Sunday, December 6, 2020 - 7:15pm | 1183The Past Week, In A Nutshell What Happened: In light of hopes for a sustained economic rebound, U.S. broad market indices pushed to new all-time highs. Remember This: “[T]he third wave is now hitting the economy harder than we thought and that the damage is likely to keep adding up in coming...